DEUTSCHE BANK AG\ - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 14 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$90,000
-21.1%
72,425
+1.9%
0.00%
Q4 2021$114,000
-72.6%
71,047
-44.4%
0.00%
Q3 2021$416,000
-5.2%
127,749
+83.9%
0.00%
Q2 2021$439,000
+3890.9%
69,454
+1473.5%
0.00%
Q3 2020$11,000
+10.0%
4,414
-31.0%
0.00%
Q4 2019$10,0006,394
+2031.3%
0.00%
Q2 2019$0300
+4185.7%
0.00%
Q3 2018$0
-100.0%
7
-99.7%
0.00%
Q2 2018$4,0002,2070.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 65,714$47,6360.04%
Laurion Capital Management LP 2,225,800$1,613,4820.01%
ETF MANAGERS GROUP, LLC 42,442$30,7660.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,2450.00%
Renaissance Technologies 936,070$6790.00%
Caption Management, LLC 75,000$54,3680.00%
St. Johns Investment Management Company, LLC 1,550$1,1240.00%
J. L. Bainbridge & Co., Inc. 10,621$7,6990.00%
D. E. Shaw & Co., Inc. 823,362$596,8550.00%
WELLS FARGO & COMPANY/MN 5,023$3,6420.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders